Experience
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Warner-Lambert Company LLC v. Sandoz GmbH*
Warner-Lambert Company LLC
Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH
Represented Pfizer group Warner-Lambert in enforcing its second medical use patent for blockbuster drug Lyrica® (pregabalin) as a neuropathic pain treatment against numerous generic companies in the UK and across Europe. Heralded as the IP case of the decade in the UK, it was heard in the Supreme Court in 2018 (having previously been before the Court of Appeal twice) on the most difficult issues in English patent law namely plausibility and infringement of second medical use patents.
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 485 (Pat), Claim number: HC-2014-001795, Patents Court
Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWCA Civ 556, Appeal numbers: A3/2015/0221 and A3/2015/0669, Court of Appeal
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 2548 (Pat), Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795, Patents Court
Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWHC 2919 (Pat), Claim number: HP-2015-000049, Patents Court
Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH v. Warner-Lambert Company LLC, [2015] EWHC 2924 (Pat), Claim number: HP-2015-000049, Patents Court
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 3153 (Pat), Claim number: HP-2015-000049, Patents Court
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2015] EWHC 3370 (Pat), Claim numbers: HP-2014-000035, HP-2014-000021, and HC-2014-001795, Patents Court
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2016] EWCA Civ 1006, Appeal numbers: A3/2015/3415, A3/2015/3602, A3/2015/3615, and A3/2016/0017, Court of Appeal
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2016] EWHC 3317 (Pat), Claim number: HP-2015-000049, Patents Court
Warner-Lambert Company LLC v. Generics (UK) Ltd (t/a Mylan) & Actavis Group PTC ehf; Sandoz GmbH, [2018] UKSC 56, Appeal numbers: UKSC 2016/0197, 2017/0069, and 2017/0078, Supreme Court of the United Kingdom
*Matter handled prior to joining Finnegan.
The Regents of the University of California & Astellas Pharma Europe Ltd.
Dr Reddy’s Laboratories (UK) Limited & Ors v. Warner-Lambert Company LLC & Anor*
Warner-Lambert Company LLC & Anor
Heraeus Medical GmbH & Anor v. Biomet UK Healthcare Limited & Ors*
Biomet UK Healthcare Limited & Ors
Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*
Boehringer Ingelheim International GmbH
Dorco Company, Ltd. v. The Gillette Company, LLC
Dorco Company, Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.